Upload
buiquynh
View
217
Download
3
Embed Size (px)
Citation preview
This event will discuss emerging research relating to the physiology, psychology and pharmacology of
pain, and its assessment and management.
This event has CPD accreditation
www.lifescienceevents.com/pain2016
#PainESC
3 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Contents
Day 1: Pathophysiology of Pain............................................................................................................... 5
First Session ............................................................................................................................................ 5
Euroscicon Welcome ............................................................................................................................... 5
Introduction by the chair ........................................................................................................................ 5
Where is pain in the brain? ..................................................................................................................... 5
Oral Presentation .................................................................................................................................... 5
The roles of Clathrin Heavy Chain-22 in human pain and touch development ...................................... 5
Q and A .................................................................................................................................................... 5
Oral Presentation .................................................................................................................................... 5
Physical pain threshold and tolerance in self-harm: methodological challenges and future directions 5
Day 1: Pathophysiology of Pain............................................................................................................... 6
Second Session ........................................................................................................................................ 6
Euroscicon Welcome ............................................................................................................................... 6
Introduction by the chair ........................................................................................................................ 6
Talk title to be confirmed ........................................................................................................................ 6
Talk title to be confirmed ........................................................................................................................ 6
Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis .................................................... 6
Oral Presentation .................................................................................................................................... 6
Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain ............. 6
Central GABA-C receptors and anti-nociception .................................................................................... 6
Day 2: Pain Assessment & Diagnosis ...................................................................................................... 7
First Session ............................................................................................................................................ 7
Euroscicon Welcome ............................................................................................................................... 7
Introduction by the chair ........................................................................................................................ 7
Talk title to be confirmed ........................................................................................................................ 7
The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained
and formidable pain category ................................................................................................................. 7
Oral Presentation .................................................................................................................................... 7
Talk title to be confirmed ........................................................................................................................ 7
Brain electrophysiological representation of multidimensional subjective experience of pain during
noxious laser heat stimulation ................................................................................................................ 7
Day 2: Pain Assessment & Diagnosis ...................................................................................................... 8
Second Session ........................................................................................................................................ 8
4 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Euroscicon Welcome ............................................................................................................................... 8
Introduction by the chair ........................................................................................................................ 8
Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms ...................... 8
Talk title to be confirmed ........................................................................................................................ 8
Oral Presentation .................................................................................................................................... 8
Behavioural pain assessment tool development and the development and initial testing of a meta
tool .......................................................................................................................................................... 8
Conceptual framework of pain in persons with mild traumatic brain injury/concussion ...................... 8
Q and A .................................................................................................................................................... 8
Day 3: Pain Management ........................................................................................................................ 9
First Session ............................................................................................................................................ 9
Euroscicon Welcome ............................................................................................................................... 9
Introduction by the chair ........................................................................................................................ 9
What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative
emotional behaviour, and postoperative pain? ..................................................................................... 9
Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients .............................................. 9
Talk tittle to be confirmed ...................................................................................................................... 9
Oral Presentation .................................................................................................................................... 9
Talk title to be confirmed ........................................................................................................................ 9
The impact of baroreflex sensitivity for the treatment of chronic pain. ................................................ 9
Day 3: Pain Management ...................................................................................................................... 10
Second Session ...................................................................................................................................... 10
Euroscicon Welcome ............................................................................................................................. 10
Introduction by the chair ...................................................................................................................... 10
Talk title to be confirmed ...................................................................................................................... 10
Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor 10
Oral Presentation .................................................................................................................................. 10
Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without
the Development of Addiction and Other Toxicities ............................................................................ 10
Adapting the cancer pain management paradigm to non-cancer pain and survivorship .................... 10
5 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 1: Pathophysiology of Pain
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair
Where is pain in the brain? Q and A
Professor Emeritus Amos D Korczyn, Tel Aviv University, Ramat, Israel
08:45 04:45 17:45 Oral Presentation Speaker to be confirmed
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Disconnecting pain - neurosurgical treatments for intractable oncological pain Q and A
Dr. Ido Strauss, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
10:00 06:00 19:00 The roles of Clathrin Heavy Chain-22 in human pain and touch development Q and A
Dr. Mike Nahorski, University of Cambridge, Cambridge, United Kingdom
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:15 07:15 20:15 Gonadal Hormones and Pain Q and A
Professor Anna Maria Aloisi, Università degli Studi di Siena, Siena, Italy
11:45 07:45 20:45 Physical pain threshold and tolerance in self-harm: methodological challenges and future directions Q and A
Dr. Olivia J. Kirtley, University of Glasgow, Glasgow, United Kingdom
12:15 08:15 21:15 Closing remarks, End of Early Session Closing remarks, End of Early Session
6 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 1: Pathophysiology of Pain
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair
Talk title to be confirmed Q and A
Dr. Luana Colloca, University of Maryland School of Nursing University of Maryland School of Medicine, Baltimore, United States
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr. Yang D.Teng, Harvard Medical School, Boston, United States
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis Q and A
Dr Marc Karam, University of Balamand, Biology Department, Kourah, Lebanon
16:00 12:00 01:00 Decreasing Tumor Necrosis Factor-alpha Solely in the Brain for Treatment of Neuropathic Pain Q and A
Professor Tracey A. Ignatowski, University at Buffalo, Buffalo, United States
16:30 12:30 01:30 Oral Presentation Speaker to be confirmed
16:45 12:45 01:45 Session Break Poster Viewing
17:15 13:15 02:15 Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain Q and A
Dr. Theodore Price, University of Texas at Dallas, Richardson, United States
17:45 13:45 02:45 Inpatient headache managament for migraines and chronic daily headaches Q and A
Dr. Priyanka Chaudhry, Baylor Comprehensive Headache Center, Dallas, United States
18:15 14:15 03:15 Central GABA-C receptors and anti-nociception Q and A
Professor Sastry Bhagavatula, The University of British Columbia, Vancouver, Canada
18:45 14:45 03:45 Closing remarks, End of Late Session
7 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 2: Pain Assessment & Diagnosis
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia
08:00 04:00 17:00 Talk title to be confirmed Q and A
Dr. Ramakrishnan Mani, University of Otago, Dunedin, New Zealand
08:30 04:30 17:30 Where does the pain come from in osteoarthritis? Q and A
Professor Graeme Jones, University of Tasmania, Hobart TAS, Australia
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Thinking outside of the joint: The role of the brain in osteoarthritic pain and stiffness Q and A
Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia
10:00 06:00 19:00 The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained and formidable pain category Q and A
Dr. Yukinori Nagakura, Aomori University, Aomori, Japan
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:15 07:15 20:15 Talk title to be confirmed Q and A
Dr. Mary Ann Muckaden, Tata Memorial Centre, Mumbai, India
11:45 07:45 20:45 Brain electrophysiological representation of multidimensional subjective experience of pain during noxious laser heat stimulation Q and A
Dr. Andrej Stancak, University of Liverpool, Liverpool, United Kingdom
12:15 08:15 21:15 Closing remarks, End of Early Session
8 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 2: Pain Assessment & Diagnosis
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair Dr Cliff Richardson, University of Manchester, Manchester, United Kingdom
14:00 10:00 23:00 Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms
Dr. Cliff Richardson, University of Manchester, Manchester, United Kingdom
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr Rhiannon Worrall, Burton Hospital, Staffordshire, United Kingdom
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Oral Presentation Speaker to be confirmed
16:00 12:00 01:00 Behavioural pain assessment tool development and the development and initial testing of a meta tool Q and A
Dr. Julie Gregory, University of Manchester, Manchester, United Kingdom
16:30 12:30 01:30 Conceptual framework of pain in persons with mild traumatic brain injury/concussion Q and A
Dr. Tatyana Mollayeva, University of Toronto, Toronto, Canada
17:00 13:00 02:00 Closing remarks, End of Late Session
9 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 3: Pain Management
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary
08:00 04:00 17:00 What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative emotional behaviour, and postoperative pain? Q and A
Dr. He Hong-Gu, National University of Singapore, Singapore
08:30 04:30 17:30 Novel morphine analogue 14-O-methylmorphine with high mu opioid receptor agonist efficacy, selectivity and affinity Q and A
Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients Q and A
Professor Jacek Kubica, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland
10:00 06:00 19:00 Talk tittle to be confirmed Q and A
Speaker to be confirmed
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:45 07:45 20:45 Talk title to be confirmed Q and A
Dr. Eleni Besi, Eastman Dental Hospital, UCLH NHS Foundation Trust, United Kingdom
12:15 08:15 21:15 The impact of baroreflex sensitivity for the treatment of chronic pain.
Dr. Kati Thieme, Philipps-University of Marburg, Marburg, Germany
12:45 08:45 21:45 Closing remarks, End of Early Session
10 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 3: Pain Management
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair Chair to be confirmed
14:00 10:00 23:00 Role of 6TM-mOR and GPCR heterodimerization in opioid induced hyperalgesia Q and A
Dr. Marino Convertino, University of North Carolina, United States
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr. Felipe Fregni, Harvard Medical School, United States
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor Q and A
Dr. Zainab Samaan, McMaster University, Hamilton, Canada
16:00 12:00 01:00 Chronic Pain and Addiction: the Crossroads
Q and A
Dr. Peter Przekop, Loma Linda University, Loma Linda, United States
16:30 12:30 01:30 Oral Presentation Speaker to be confirmed
16:45 12:45 01:45 Session Break Poster Viewing
17:15 13:15 02:15 Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without the Development of Addiction and Other Toxicities Q and A
Dr. Victor J. Hruby, Regents Professor, Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA
17:45 13:45 02:45 Adapting the cancer pain management paradigm to non-cancer pain and survivorship Q and A
Dr. Pippa Hawley, BC Cancer Agency, Vancouver, Canada
18:15 14:15 03:15 Closing remarks, End of Late Session
11 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
12 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
MEDIA SPONSORS
Missing Speakers
It is unfortunate that occasionally a speaker cannot attend. Whilst we do everything possible to ensure that our speakers are present at the event we apologise in advance if you were at a session where a speaker could not attend. We always try to keep our agendas as up to date as possible, however if a speaker cancels the night before an event or on the day, there is little we can do to rectify this.